Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP

This article has been corrected: The correct order of author affiliations is given below:

Hyunchul Jung^1,4,*, Hae Yong Yoo^2,*, Seung Ho Lee^2,*, Sohyun Shin³, Sang Cheol Kim⁴, Sejoon Lee⁴, Je-Gun Joung⁴, Jae-Yong Nam^2,4, Daeun Ryu^2,4, Jae Won Yun^4,5, Jung Kyoon Choi¹, Ambarnil Ghosh⁵, Kyeong Kyu Kim⁵, Seok Jin Kim⁶, Won Seog Kim⁶, Woong-Yang Park¹ and Young Hyeh Ko³

¹ Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea

² Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea

³ Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

⁴ Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea

⁵ Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea

⁶ Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

* These authors have contributed equally to this work

Original article: Oncotarget. 2017; 8:17038-17049. https://doi.org/10.18632/oncotarget.14928